Compliance Policy Guide Sec. 230.110-Registration of Blood Banks, Other Firms Collecting, Manufacturing, Preparing, or Processing Human Blood or Blood Products; Withdrawal, 38838 [2012-15907]

Download as PDF 38838 Federal Register / Vol. 77, No. 126 / Friday, June 29, 2012 / Notices deadline specified in the DATES section of this notice. Please provide your full name (as it appears on your government-issued photographic identification), address, organization, telephone, and email address. At the time of registration, you will be asked to designate if you plan to attend in person or via webinar. You will receive a registration confirmation with instructions for your arrival at the CMS complex or you will be notified that the seating capacity has been reached. IV. Security, Building, and Parking Guidelines This meeting will be held in a Federal government building; therefore, Federal security measures are applicable. We recommend that confirmed registrants arrive reasonably early, but no earlier than 45 minutes prior to the start of the meeting, to allow additional time to clear security. Security measures include the following: • Presentation of government-issued photographic identification to the Federal Protective Service or Guard Service personnel. • Inspection of vehicle’s interior and exterior (this includes engine and trunk inspection) at the entrance to the grounds. Parking permits and instructions will be issued after the vehicle inspection. • Inspection, via metal detector or other applicable means, of all persons entering the building. We note that all items brought into CMS, whether personal or for the purpose of presentation or to support a presentation, are subject to inspection. We cannot assume responsibility for coordinating the receipt, transfer, transport, storage, set-up, safety, or timely arrival of any personal belongings or items used for presentation or to support a presentation. mstockstill on DSK4VPTVN1PROD with NOTICES Note: Individuals who are not registered in advance will not be permitted to enter the building and will be unable to attend the meeting. The public may not enter the building earlier than 45 minutes prior to the convening of the meeting. All visitors must be escorted in areas other than the lower and first floor levels in the Central Building. Authority: 5 U.S.C. App. 2, section 10(a). Dated: June 26, 2012. Marilyn Tavenner, Acting Administrator, Centers for Medicare & Medicaid Services. [FR Doc. 2012–15997 Filed 6–26–12; 4:15 pm] DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Health Resources and Services Administration [Docket No. FDA–2012–D–0558] Lists of Designated Primary Medical Care, Mental Health, and Dental Health Professional Shortage Areas Compliance Policy Guide Sec. 230.110—Registration of Blood Banks, Other Firms Collecting, Manufacturing, AGENCY: Health Resources and Services Preparing, or Processing Human Blood Administration, Department of Health and Human Services. or Blood Products; Withdrawal ACTION: Notice. AGENCY: Food and Drug Administration, SUMMARY: This notice advises the public HHS. of the published lists of all geographic ACTION: Notice; withdrawal. areas, population groups, and facilities designated as primary medical care, mental health, and dental health SUMMARY: The Food and Drug Administration (FDA) is announcing the professional shortage areas (HPSAs) as of April 1, 2012, available on the Health withdrawal of the compliance policy Resources and Services Administration guide (CPG) entitled ‘‘Sec. 230.110 (HRSA) Web site at https:// Registration of Blood Banks, Other bhpr.hrsa.gov/shortage/. Firms Collecting, Manufacturing, HPSAs are designated or withdrawn by Preparing, or Processing Human Blood the Secretary of Health and Human or Blood Products (CPG 7134.01),’’ Services (HHS) under the authority of dated June 17, 1974. section 332 of the Public Health Service DATES: The withdrawal is effective June (PHS) Act and 42 CFR part 5. 29, 2012. FOR FURTHER INFORMATION CONTACT: Requests for further information on the FOR FURTHER INFORMATION CONTACT: HPSA designations listed on the HRSA Robert L. Hummel, Division of Web site below and requests for Compliance Policy (HFC–230), Food additional designations, withdrawals, or and Drug Administration, 12420 reapplication for designation should be Parklawn Dr., ELEM–4152, Rockville, submitted to Andy Jordan, Office of MD 20857, 301–796–4510. Shortage Designation, Bureau of Health SUPPLEMENTARY INFORMATION: FDA issued the CPG entitled ‘‘Sec. 230.110 Registration of Blood Banks, Other Firms Collecting, Manufacturing, Preparing, or Processing Human Blood or Blood Products (CPG 7134.01)’’ on June 17, 1974. We originally issued CPG 7134.01 entitled ‘‘Establishment Registration and Product Listing for Manufacturers of Human Blood and Blood Products,’’ to provide FDA’s current thinking regarding the registration required by 21 CFR part 607 of blood banks and other establishments collecting, manufacturing, preparing, or processing human blood or blood products. Since the last update to CPG 7134.01 in 2000, the regulations for blood establishment registration under part 607 have been amended several times. FDA is withdrawing CPG 7134.01 because it is obsolete. Dated: June 13, 2012. Dara Corrigan, Associate Commissioner for Regulatory Affairs. [FR Doc. 2012–15907 Filed 6–26–12; 4:15 pm] BILLING CODE 4160–01–P BILLING CODE 4120–01–P VerDate Mar<15>2010 16:52 Jun 28, 2012 Jkt 226001 PO 00000 Frm 00074 Fmt 4703 Sfmt 4703 Professions, Health Resources and Services Administration, Room 9A–55, Parklawn Building, 5600 Fishers Lane, Rockville, Maryland 20857; (301) 594– 0816. SUPPLEMENTARY INFORMATION: Background: Section 332 of the PHS Act, 42 U.S.C. 254e, provides that the Secretary of HHS shall designate HPSAs based on criteria established by regulation. HPSAs are defined in section 332 to include (1) urban and rural geographic areas with shortages of health professionals, (2) population groups with such shortages, and (3) facilities with such shortages. Section 332 further requires that the Secretary annually publish a list of the designated geographic areas, population groups, and facilities. The lists of HPSAs are to be reviewed at least annually and revised as necessary. HRSA’s Bureau of Health Professions (BHPr) has the responsibility for designating and updating HPSAs. Public or private nonprofit entities are eligible to apply for assignment of National Health Service Corps (NHSC) personnel to provide primary care, dental, or mental health services in these HPSAs. NHSC health E:\FR\FM\29JNN1.SGM 29JNN1

Agencies

[Federal Register Volume 77, Number 126 (Friday, June 29, 2012)]
[Notices]
[Page 38838]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-15907]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2012-D-0558]


Compliance Policy Guide Sec. 230.110--Registration of Blood 
Banks, Other Firms Collecting, Manufacturing, Preparing, or Processing 
Human Blood or Blood Products; Withdrawal

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; withdrawal.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing the 
withdrawal of the compliance policy guide (CPG) entitled ``Sec. 230.110 
Registration of Blood Banks, Other Firms Collecting, Manufacturing, 
Preparing, or Processing Human Blood or Blood Products (CPG 7134.01),'' 
dated June 17, 1974.

DATES: The withdrawal is effective June 29, 2012.

FOR FURTHER INFORMATION CONTACT: Robert L. Hummel, Division of 
Compliance Policy (HFC-230), Food and Drug Administration, 12420 
Parklawn Dr., ELEM-4152, Rockville, MD 20857, 301-796-4510.

SUPPLEMENTARY INFORMATION: FDA issued the CPG entitled ``Sec. 230.110 
Registration of Blood Banks, Other Firms Collecting, Manufacturing, 
Preparing, or Processing Human Blood or Blood Products (CPG 7134.01)'' 
on June 17, 1974. We originally issued CPG 7134.01 entitled 
``Establishment Registration and Product Listing for Manufacturers of 
Human Blood and Blood Products,'' to provide FDA's current thinking 
regarding the registration required by 21 CFR part 607 of blood banks 
and other establishments collecting, manufacturing, preparing, or 
processing human blood or blood products. Since the last update to CPG 
7134.01 in 2000, the regulations for blood establishment registration 
under part 607 have been amended several times. FDA is withdrawing CPG 
7134.01 because it is obsolete.

    Dated: June 13, 2012.
Dara Corrigan,
Associate Commissioner for Regulatory Affairs.
[FR Doc. 2012-15907 Filed 6-26-12; 4:15 pm]
BILLING CODE 4160-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.